Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial

The Lancet

Volumn 393, Issue 10187, 2019, Pages 2201-2212

  Spahn, Donat R ^a   Schoenrath, Felix ^b,c   Spahn, Gabriela H ^a   Seifert, Burkhardt ^d   Stein, Philipp ^a   Theusinger, Oliver M ^d   Kaserer, Alexander ^a   Hegemann, Inga ^a   Hofmann, Axel ^a,e   Maisano, Francesco ^a   Falk, Volkmar ^b,c,f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FERRIC CARBOXYMALTOSE; FERRITIN; FOLIC ACID; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; FERRIC ION; MALTOSE;

ACUTE HEART INFARCTION; AGED; ARTICLE; CLINICAL PRACTICE; CONSULTATION; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE REGISTRY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; ESTIMATED GLOMERULAR FILTRATION RATE; EUROSCORE; EXTRACORPOREAL OXYGENATION; FEMALE; FERRITIN BLOOD LEVEL; HEALTH CARE SYSTEM; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTENSIVE CARE; IRON DEFICIENCY ANEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; COMPLICATION; HEART DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PREOPERATIVE CARE; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; FOLIC ACID; HEART DISEASES; HUMANS; MALE; MALTOSE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TIME FACTORS; VITAMIN B 12;

EID: 85064631023     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)32555-8     Document Type: Article

References (34)

1. Ranucci, M, Baryshnikova, E, Castelvecchio, S, Pelissero, G, Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 96 (2013), 478–485.
2. Klein, AA, Collier, TJ, Brar, MS, et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK – the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia 71 (2016), 627–635.
3. Kassebaum, NJ, Jasrasaria, R, Naghavi, M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 123 (2014), 615–624.
4. Hoes, MF, Grote Beverborg, N, Kijlstra, JD, et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail 20 (2018), 910–919.
5. Cappellini, MD, Comin-Colet, J, de Francisco, A, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol 92 (2017), 1068–1078.
6. Munoz, M, Acheson, AG, Auerbach, M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 72 (2017), 233–247.
7. Anker, SD, Comin Colet, J, Filippatos, G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361 (2009), 2436–2448.
8. Jankowska, EA, Tkaczyszyn, M, Suchocki, T, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail 18 (2016), 786–795.
9. Piednoir, P, Allou, N, Driss, F, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur J Anaesthesiol 28 (2011), 796–801.
10. Theusinger, OM, Kind, SL, Seifert, B, Borgeat, L, Gerber, C, Spahn, DR, Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus 12 (2014), 195–203.
11. Goodnough, LT, Monk, TG, Andriole, GL, Current concepts: erythropoietin therapy. N Engl J Med 336 (1997), 933–938.
12. Yoon, S, Rhee, SJ, Heo, SJ, et al. Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon((R)) and Eprex((R)) following a single subcutaneous administration in healthy male volunteers. Drug Des Devel Ther 11 (2017), 3127–3135.
13. Head, SJ, da Costa, BR, Beumer, B, et al. Adverse events while awaiting myocardial revascularization: a systematic review and meta–analysis. Eur J Cardiothorac Surg 52 (2017), 206–217.
14. Theusinger, OM, Leyvraz, PF, Schanz, U, Seifert, B, Spahn, DR, Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 107 (2007), 923–927.
15. Froessler, B, Palm, P, Weber, I, Hodyl, NA, Singh, R, Murphy, EM, The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg 264 (2016), 41–46.
16. Geng, S, Chen, K, Yuan, R, et al. The persistence of low–grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun, 7, 2016, 13436.
17. Anand, IS, Gupta, P, Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation 138 (2018), 80–98.
18. Mazer, CD, Whitlock, RP, Fergusson, DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 377 (2017), 2133–2144.
19. Siregar, S, Groenwold, RH, de Mol, BA, et al. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow–up?. Eur J Cardiothorac Surg 44 (2013), 875–883.
20. Yoo, YC, Shim, JK, Kim, JC, Jo, YY, Lee, JH, Kwak, YL, Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 115 (2011), 929–937.
21. Ferraris, VA, Brown, JR, Despotis, GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91 (2011), 944–982.
22. Boer, C, Meesters, MI, Milojevic, M, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth 53 (2017), 79–111.
23. Meybohm, P, Herrmann, E, Steinbicker, AU, et al. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome: a prospective, multicenter cohort study with a noninferiority design. Ann Surg 264 (2016), 203–211.
24. Leahy, MF, Hofmann, A, Towler, S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 57 (2017), 1347–1358.
25. Gross, I, Seifert, B, Hofmann, A, Spahn, DR, Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion 55 (2015), 1075–1081.
26. Shander, A, Hofmann, A, Ozawa, S, Theusinger, OM, Gombotz, H, Spahn, DR, Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 50 (2010), 753–765.
27. Johansson, PI, Rasmussen, AS, Thomsen, LL, Intravenous iron isomaltoside 1000 (Monofer((R))) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang 109 (2015), 257–266.
28. Toblli, JE, Cao, G, Giani, JF, Dominici, FP, Angerosa, M, Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds. Drug Des Devel Ther 11 (2017), 2251–2263.
29. Susantitaphong, P, Alqahtani, F, Jaber, BL, Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis. Am J Nephrol 39 (2014), 130–141.
30. Litton, E, Baker, S, Erber, WN, et al., for the IRONMAN Investigators. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness. Intensive Care Med 42 (2016), 1715–1722.
31. Khalafallah, AA, Yan, C, Al-Badri, R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol 3 (2016), e415–ee25.
32. Sowade, O, Ziemer, S, Sowade, B, et al. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery. J Lab Clin Med 129 (1997), 376–383.
33. Penny-Dimri, JC, Cochrane, AD, Perry, LA, Smith, JA, Characterising the role of perioperative erythropoietin for preventing acute kidney injury after cardiac surgery: systematic review and meta-analysis. Heart Lung Circ 25 (2016), 1067–1076.
34. Oh, SW, Chin, HJ, Chae, DW, Na, KY, Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci 27 (2012), 506–511.